VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
KZR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
KZRKezar Life Sciences, Inc.
$7.29$54M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksKZRQuarterly Financials

Kezar Life Sciences, Inc. (KZR) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Kezar Life Sciences, Inc. (KZR) quarterly income statement — complete revenue, gross profit & net income history

KZR Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000007M000000000
Revenue Growth %-------100%-------------
Cost of Goods Sold0176K000000260K280K278K000000000
COGS % of Revenue----------3.97%---------
Gross Profit0-176K000000-260K-280K6.72M000000000
Gross Margin %----------96.03%---------
Gross Profit Growth %----100%100%-100%-------------
Operating Expenses7.37M8.15M11.71M14.6M17.63M21.56M21.95M23.38M23.45M28.12M32.25M26.78M24.52M20.03M18.93M16.32M15.88M14.1M14.5M13.01M
OpEx % of Revenue----------460.7%---------
Selling, General & Admin5.21M3.25M4.8M5.02M5.45M5.54M5.71M5.6M6.28M5.48M8.79M5.79M6.21M5.17M5.07M4.98M4.93M4.32M3.97M3.67M
SG&A % of Revenue----------125.56%---------
Research & Development1.54M5.08M6.91M9.58M12.18M16.03M16.24M16.3M17.17M22.64M23.74M21M18.32M14.86M13.86M11.35M10.94M9.78M10.53M9.34M
R&D % of Revenue----------339.11%---------
Other Operating Expenses612K-176K000-12K01000K00-278K000000000
Operating Income-7.37M-8.33M-11.71M-14.6M-17.63M-21.56M-21.95M-23.38M-23.71M-28.4M-25.53M-26.78M-24.52M-20.03M-18.93M-16.32M-15.88M-14.1M-14.5M-13.01M
Operating Margin %-----------364.67%---------
Operating Income Growth %58.22%61.38%46.62%37.57%25.65%24.08%14.02%12.7%3.32%-41.77%-34.87%-64.09%-54.45%-42.05%-30.54%-25.47%-21.69%-27.42%-25.52%-32.03%
EBITDA-7.37M-8.15M-11.49M-14.36M-17.38M-21.3M-21.69M-23.12M-23.45M-28.12M-25.25M-26.54M-24.27M-17.83M-18.47M-15.89M-15.46M-13.72M-14.12M-12.64M
EBITDA Margin %-----------360.7%---------
EBITDA Growth %57.62%61.74%47.03%37.91%25.9%24.24%14.1%12.86%3.35%-57.71%-36.71%-66.97%-56.94%-30.01%-30.79%-25.77%-21.97%-28.19%-27.15%-33.23%
D&A (Non-Cash Add-back)0176K227K243K251K259K260K261K260K280K278K249K259K0458K431K417K387K378K373K
EBIT0-8.33M-10.69M-13.4M-16.21M-19.83M-19.91M-21.15M-21.26M-31.86M-22.71M-23.92M-21.83M-17.83M-17.54M-15.91M-15.77M-13.91M-14.46M-12.96M
Net Interest Income0801K488K895K1.07M1.34M1.64M1.84M2.05M2.33M2.42M2.48M2.33M1.85M1.08M136K-146K-109K37K47K
Interest Income609K801K1.03M1.2M1.42M1.73M2.04M2.24M2.45M2.73M2.82M2.86M2.69M2.2M1.39M408K108K50K37K47K
Interest Expense00538K302K347K389K403K401K400K399K396K385K370K349K310K272K254K159K00
Other Income/Expense1.61M-6.22M488K895K1.07M1.34M1.64M1.84M2.05M-3.86M2.42M2.48M2.33M1.85M1.08M136K-146K-109K37K47K
Pretax Income-5.76M-14.55M-11.23M-13.7M-16.56M-20.22M-20.31M-21.55M-21.66M-32.26M-23.1M-24.31M-22.2M-18.18M-17.85M-16.19M-16.02M-14.21M-14.46M-12.96M
Pretax Margin %-----------330.04%---------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-5.76M-14.55M-11.23M-13.7M-16.56M-20.22M-20.31M-21.55M-21.66M-32.26M-23.1M-24.31M-22.2M-18.18M-17.85M-16.19M-16.02M-14.21M-14.46M-12.96M
Net Margin %-----------330.04%---------
Net Income Growth %65.23%28.05%44.73%36.4%23.56%37.33%12.08%11.36%2.44%-77.44%-29.45%-50.17%-38.54%-27.93%-23.41%-24.88%-23.32%-29.9%-28.11%-36.44%
Net Income (Continuing)-5.76M-14.55M-11.23M-13.7M-16.56M-20.22M-20.31M-21.55M-21.66M-32.26M-23.1M-24.31M-22.2M-18.18M-17.85M-16.19M-16.02M-14.21M-14.46M-12.96M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.78-1.99-1.53-1.87-2.27-2.77-0.28-0.30-0.30-0.44-0.32-0.34-0.28-0.23-0.23-0.25-0.27-0.25-0.28-0.25
EPS Growth %65.64%28.16%-446.43%-523.33%-656.67%-529.55%12.5%11.76%-7.14%-91.3%-39.13%-36%-3.7%8%17.86%0%-8%-13.64%-21.74%-13.64%
EPS (Basic)-0.78-1.99-1.53-1.87-2.27-2.77-0.28-0.30-0.30-0.44-0.32-0.34-0.28-0.23-0.23-0.25-0.27-0.25-0.28-0.25
Diluted Shares Outstanding7.34M7.32M7.32M7.31M7.31M7.3M72.96M72.88M72.8M72.74M72.68M72.46M72.33M72.23M72.15M64.28M60.63M55.98M52.05M51.9M
Basic Shares Outstanding7.34M7.32M7.32M7.31M7.31M7.3M72.96M72.88M72.8M72.74M72.68M72.46M72.33M72.23M72.15M64.28M60.63M55.98M52.05M51.9M
Dividend Payout Ratio--------------------